Genital Herpes
📧 Sign up to get email alerts when something new happens for Genital Herpes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes [Phase 1]
This Phase 1 study assessed the safety, pharmacokinetics, and antiviral activity of ABI-5366 in healthy participants and HSV-2 seropositive …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes [Phase 1]
Phase 1 study to evaluate the safety, pharmacokinetics, and tolerability of ABI-1179 in healthy subjects and HSV-2 seropositive individuals …
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Viral Infections in Healthy and Immunocompromised Hosts
An NIAID-sponsored clinical trial is examining viral infections in healthy and immunocompromised hosts. It is currently recruiting and focus…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination [Phase 1]
This clinical trial update describes a Phase 1 study to evaluate the safety, tolerability, and immunogenicity of an HSV-2–targeted mRNA vacc…
-
FDA approval · 2025-11-12FDA Approved: VALTREX — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Valtrex (valacyclovir hydrochloride) filed by GlaxoSmithKline LLC under NDA020487. The action up…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions [Phase 1]
Phase 1 clinical trial to assess safety, tolerability, and immune responses of an investigational vaccine to prevent genital herpes lesions …
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes [Phase 1, Phase 2]
A completed Phase 1/2 study by GlaxoSmithKline evaluated a targeted immunotherapy against herpes simplex virus, assessing safety, reactogeni…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes [Phase 1, Phase 2]
A Phase 1/2 clinical trial of mRNA-1608, Moderna's HSV-2 therapeutic vaccine, in healthy adults with recurrent genital herpes has completed.
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
A completed epidemiological study sponsored by GlaxoSmithKline evaluating the performance of healthcare tools to understand HSV-2 genital in…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Study of 2LHERP® in Genital Herpes Infections [Phase 4]
Phase 4 trial update for 2LHERP® in genital herpes infections; study terminated.
-
FDA approval · 2023-06-07FDA Approved: FAMCICLOVIR — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for Macleods Pharmaceuticals Limited to market famciclovir (FAMCICLOVIR) as a generic. This expa…
-
FDA approval · 2023-05-11FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for valacyclovir hydrochloride (generic valacyclovir) from Mylan Pharmaceuticals Inc., under AND…
-
FDA approval · 2023-05-08FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Valacyclovir hydrochloride from Aurobindo Pharma Limited. The approval confirms continued market…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes [Phase 2]
Phase 2 trial update for a new antiviral against Genital Herpes has been terminated with results posted.
-
FDA approval · 2023-04-17FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved a supplemental application for valacyclovir hydrochloride submitted by Jubilant Cadista Pharmaceuticals Inc.
-
FDA approval · 2023-03-23FDA Approved: VALACYCLOVIR — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
FDA approved a supplemental application for valacyclovir from Sun Pharmaceutical Industries, a generic antiviral indicated for herpes infect…
-
FDA approval · 2023-03-09FDA Approved: ACYCLOVIR SUSPENSION — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved ACYCLOVIR SUSPENSION under Original Application for a generic acyclovir suspension by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2023-02-23FDA Approved: VALACYCLOVIR — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for Valacyclovir by Quallent Pharmaceuticals Health LLC under ANDA203047, indicating a regulatory up…
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621 [Phase 2]
Phase 2 clinical trial update evaluating the safety and efficacy of UB-621 for genital herpes.
-
FDA approval · 2022-08-18FDA Approved: ACYCLOVIR — Original Application (Advagen Pharma Limited)
FDA approves the original ANDA for acyclovir from Advagen Pharma Limited.
-
FDA approval · 2022-07-01FDA Approved: ACYCLOVIR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original ANDA for generic acyclovir, enabling brand-generic competition for this antiviral. The approva…
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals [Phase 2]
A Phase 2 clinical trial investigating UB-621, a monoclonal antibody targeting herpes simplex virus, for adult recurrent genital herpes infe…
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2 [Phase 2]
Phase 2 trial update on a new antiviral for genital herpes type 2 (HSV-2) showing completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Melatonin Effects on Genital Herpes in Brazilian Women [Phase 4]
Phase 4 clinical trial evaluating melatonin effects on genital herpes in Brazilian women has completed.
-
FDA approval · 2021-11-15FDA Approved: ACYCLOVIR — Original Application (Solco Healthcare US, LLC)
FDA approved the original application for acyclovir from Solco Healthcare US, LLC (oral generic).